FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07576452

Title field or adapter rule

{'original_value': 'FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:36.594079+00:00

Published At

2026-10-21T00:00:00+00:00

Record Updated At

2026-10-21

Source Retrieved At

2026-10-31T22:18:58.295941+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Ulcerative Colitis (UC)"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-21", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07576452"

protocolSection.identificationModule.officialTitle

"FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Ulcerative Colitis (UC) (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Time to efficacy (1: infliximab 2: filgotinib 3: ustekinumab 4: vedolizumab)'], 'description': 'Follow the processing sequence based on time to efficacy.', 'name': '1: infliximab 2: filgotinib 3: ustekinumab 4: vedolizumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Safety profile (1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib)'], 'description': 'Follow the processing sequence based on safety.', 'name': '1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['French current use* (1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab)'], 'description': 'Follow the processing sequence based on French current use.', 'name': '1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Convenience (1: filgotinib 2: ustekinumab 3: vedolizumab 4: infliximab)'], 'description': 'Follow the processing sequence based on convenience.', 'name': '1: filgotinib 2: ustekinumab 3: vedolizumab 4: infliximab)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• 1: infliximab 2: filgotinib 3: ustekinumab 4: vedolizumab (protocolSection.armsInterventionsModule.interventions[].name)
• 1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib (protocolSection.armsInterventionsModule.interventions[].name)
• 1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab (protocolSection.armsInterventionsModule.interventions[].name)
• 1: filgotinib 2: ustekinumab 3: vedolizumab 4: infliximab) (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.